Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Anavex Life Sciences Corp.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |
| Newly Registered Securities | ||||||||||||
| Fees to Be Paid | Equity | Common Stock, $0.001 par value per share | 457(o) | (1) | (1) | $150,000,000 | $147.60per $1,000,000 | $22,140 (2) | ||||
| Fees Previously Paid | - | - | - | - | - | - | - | - | ||||
| Carry Forward Securities | ||||||||||||
| Carry Forward Securities | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Offering Amounts | $150,000,000 | - | $22,140 (2) | |||||||||
| Total Fees Previously Paid | - | |||||||||||
| Total Fee Offsets | - | |||||||||||
| Net Fee Due | $22,140 | |||||||||||
| (1) | Pursuant to Instruction 2.A(iii)(b) of Item 16(b) of Form S-3, this information is not required to be included. An indeterminate aggregate initial offering price or number of shares of Common Stock is being registered as may be issued at indeterminate prices from time to time with an aggregate initial offering price not to exceed $150,000,000. |
| (2) | Calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended. |
